Diagnostic and biological significance of microRNA-192 in pancreatic ductal adenocarcinoma

Oncology Reports

Volumn 30, Issue 1, 2013, Pages 276-284

  Zhao, Chenyan ^a,b   Zhang, Jing ^a   Zhang, Shuhui ^a   Yu, Danghui ^a   Chen, Ying ^a   Liu, Qinghua ^a   Shi, Min ^a   Ni, Canrong ^a   Zhu, Minghua ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Apoptosis; Diagnosis; Growth; microRNA; Pancreatic ductal adenocarcinoma

Indexed keywords

BIOLOGICAL MARKER; COLLAGEN TYPE 1; CYCLIN D1; CYCLIN D2; CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE 4; MICRORNA 192; PROTEIN P107; PROTEIN P130; PROTEIN P21; PROTEIN P27; RETINOBLASTOMA PROTEIN; S PHASE KINASE ASSOCIATED PROTEIN 2; SMAD INTERACTING PROTEIN 1; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CELL; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DOWN REGULATION; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TUMOR GROWTH; UPREGULATION; WESTERN BLOTTING;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; CARCINOMA, PANCREATIC DUCTAL; CELL CYCLE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COLLAGEN; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICE; MICE, NUDE; MICRORNAS; MIDDLE AGED; NERVE TISSUE PROTEINS; PANCREAS; RNA-BINDING PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 84878199410     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2420     Document Type: Article

References (33)

1. Jemal A, Siegel R, Xu J and Ward E: Cancer statistics, 2010. CA Cancer J Clin 60: 277-300, 2010.
2. Li D, Xie K, Wolff R and Abbruzzese JL: Pancreatic cancer. Lancet 363: 1049-1057, 2004. (Pubitemid 38410779)
3. Brand RE and Matamoros A: Imaging techniques in the evaluation of adenocarcinoma of the pancreas. Dig Dis 16: 242-252, 1998. (Pubitemid 128531138)
4. Goonetilleke KS and Siriwardena AK: Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer. Eur J Surg Oncol 33: 266-270, 2007. (Pubitemid 46488663)
5. Kawai S, Suzuki K, Nishio K, et al: Smoking and serum CA19-9 levels according to Lewis and secretor genotypes. Int J Cancer 123: 2880-2884, 2008.
6. Koopmann J, Rosenzweig CN, Zhang Z, et al: Serum markers in patients with resectable pancreatic adenocarcinoma: macrophage inhibitory cytokine 1 versus CA19-9. Clin Cancer Res 12: 442-446, 2006. (Pubitemid 43166133)
7. Bünger S, Laubert T, Roblick UJ and Habermann JK: Serum biomarkers for improved diagnostic of pancreatic cancer: a current overview. J Cancer Res Clin Oncol 137: 375-389, 2011.
8. Cortez MA, Welsh JW and Calin GA: Circulating microRNAs as noninvasive biomarkers in breast cancer. Recent Results Cancer Res 195: 151-161, 2012.
9. Redova M, Poprach A, Nekvindova J, et al: Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma. J Transl Med 10: 55, 2012.
10. Jung DE, Wen J, Oh T and Song SY: Differentially expressed microRNAs in pancreatic cancer stem cells. Pancreas 40: 1180-1187, 2011.
11. Keller A, Leidinger P, Gislefoss R, et al: Stable serum miRNA profiles as potential tool for non-invasive lung cancer diagnosis. RNA Biol 8: 506-516, 2011.
12. Mitchell PS, Parkin RK, Kroh EM, et al: Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105: 10513-10518, 2008.
13. Mees ST, Mardin WA, Wendel C, et al: EP300 - a miRNA-regulated metastasis suppressor gene in ductal adenocarcinomas of the pancreas. Int J Cancer 126: 114-124, 2010.
14. Wang J, Chen J, Chang P, et al: MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease. Cancer Prev Res 2: 807-813, 2009.
15. Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ and Lötvall JO: Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9: 654-659, 2007. (Pubitemid 47214727)
16. Rabinowits G, Gercel-Taylor C, Day JM, Taylor DD and Kloecker GH: Exosomal microRNA: a diagnostic marker for lung cancer. Clin Lung Cancer 10: 42-46, 2009.
17. Kosaka N, Iguchi H, Yoshioka Y, Takeshita F, Matsuki Y and Ochiya T: Secretory mechanisms and intercellular transfer of microRNAs in living cells. J Biol Chem 285: 17442-17452, 2010.
18. Song B, Wang Y, Kudo K, Gavin EJ, Xi Y and Ju J: miR-192 regulates dihydrofolate reductase and cellular proliferation through the p53-microRNA circuit. Clin Cancer Res 14: 8080-8086, 2008.
19. Feng S, Cong S, Zhang X, et al: MicroRNA-192 targeting retinoblastoma 1 inhibits cell proliferation and induces cell apoptosis in lung cancer cells. Nucleic Acids Res 39: 6669-6678, 2011.
20. Vermeulen K, Van Bockstaele DR and Berneman ZN: The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer. Cell Prolif 36: 131-149, 2003. (Pubitemid 36808270)
21. Classon M, Salama S, Gorka C, Mulloy R, Braun P and Harlow E: Combinatorial roles for pRB, p107, and p130 in E2F-mediated cell cycle control. Proc Natl Acad Sci USA 97: 10820-10825, 2000.
22. Frescas D and Pagano M: Deregulated proteolysis by the F-box proteins SKP2 and beta-TrCP: tipping the scales of cancer. Nat Rev Cancer 8: 438-449, 2008. (Pubitemid 351744963)
23. Braun CJ, Zhang X, Savelyeva I, et al: p53-Responsive microRNAs 192 and 215 are capable of inducing cell cycle arrest. Cancer Res 68: 10094-10104, 2008.
24. Cloonan N, Brown MK, Steptoe AL, et al: The miR-17-5p microRNA is a key regulator of the G1/S phase cell cycle transition. Genome Biol 9: R127, 2008.
25. Lim LP, Lau NC, Garrett-Engele P, et al: Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433: 769-773, 2005. (Pubitemid 40292988)
26. Georges SA, Biery MC, Kim SY, et al: Coordinated regulation of cell cycle transcripts by p53-inducible microRNAs, miR-192 and miR-215. Cancer Res 68: 10105-10112, 2008.
27. Zhang S, Hao J, Xie F, et al: Downregulation of miR-132 by promoter methylation contributes to pancreatic cancer development. Carcinogenesis 32: 1183-1189, 2011.
28. Katoh M and Katoh M: Integrative genomic analyses of ZEB2: Transcriptional regulation of ZEB2 based on SMADs, ETS1, HIF1α, POU/OCT, and NF-κB. Int J Oncol 34: 1737-1742, 2009.
29. Mejlvang J, Kriajevska M, Vandewalle C, et al: Direct repression of cyclin D1 by SIP1 attenuates cell cycle progression in cells undergoing an epithelial mesenchymal transition. Mol Biol Cell 18: 4615-4624, 2007. (Pubitemid 350060186)
30. Sayan AE, Griffiths TR, Pal R, et al: SIP1 protein protects cells from DNA damage-induced apoptosis and has independent prognostic value in bladder cancer. Proc Natl Acad Sci USA 106: 14884-14889, 2009.
31. Grzesiak JJ and Bouvet M: The alpha2beta1 integrin mediates the malignant phenotype on type I collagen in pancreatic cancer cell lines. Br J Cancer 94: 1311-1319, 2006.
32. Menke A, Philippi C, Vogelmann R, et al: Down-regulation of E-cadherin gene expression by collagen type I and type III in pancreatic cancer cell lines. Cancer Res 61: 3508-3517, 2001. (Pubitemid 32695048)
33. Imamichi Y, König A, Gress T and Menke A: Collagen type I-induced Smad-interacting protein 1 expression downregulates E-cadherin in pancreatic cancer. Oncogene 26: 2381-2385, 2007. (Pubitemid 46572808)